Stock Trading Ideas

Trump's Win, Economic Challenges Lead to Tougher Outlook for Renewable Energy Stocks: Morgan Stanley

Stock Of The Day: Is Pfizer Set Up To Rally?

Disney Q4 Earnings Show 'A Lot To Like': Analyst Calls It 'High-Quality' Profit Growth Performer

Stock Of The Day: Is Pfizer Set Up To Rally?

Disney Q4 Earnings Show 'A Lot To Like': Analyst Calls It 'High-Quality' Profit Growth Performer

Boeing Begins Layoffs: Is The 737 MAX Recovery Enough To Lift BA Stock?

Palantir Prepares Nasdaq Move: Could Nasdaq-100 Be Next?

Boeing Begins Layoffs: Is The 737 MAX Recovery Enough To Lift BA Stock?

Palantir Prepares Nasdaq Move: Could Nasdaq-100 Be Next?

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

European And US Vaccine Stocks Are Under Pressure - Here's WHy

Trading Ideas Recent News

Tradepulse Power Inflow Alert: Coinbase Global Inc. Receives Alert And Climbs Over 25 Points

4 Stocks to Sell Before Trump's Tariffs Take Effect

Dust settling from 2024 election as companies grapple with potential tariffs under second Trump term. List of stocks that may be impacted.

Crude Oil Dips Over 2%; Bloom Energy Shares Spike Higher

Gilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver Disease

Gilead shares data from its Phase 3 ASSURE study, showing 81% of PBC patients treated with Livdelzi achieved a composite response with continued safety.

JP Morgan Downgrades Gene Therapy Focused Bluebird Bio, Cites Limited Funding Options

Bluebird Bio's Q3 earnings report showed a narrower-than-expected EPS loss but missed sales targets, leading to a JP Morgan downgrade and cash concerns.

Tapestry Poised For Solid Growth After Capri Merger Termination, Analysts Cite Struggles And Missteps At Capri

Tapestry ended its merger with Capri Holdings, but analysts remain upbeat on Tapestry's growth while downgrading Capri's outlook.

Tesla To Partner With Lyft, Uber? Analyst Has 'Rising Conviction' For Future Partnership

RBC raises the price target on Tesla thanks to rising confidence in the revenue opportunity for FSD. Analysts make the case for partnerships with Uber and Lyft.

Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline

Eyenovia's Phase 3 CHAPERONE study fails to meet its primary endpoint, prompting a review of strategic alternatives, including potential mergers or asset sales.

Applied Materials Reports Solid Q4 Beat, Analysts Express Concern Around High Exposure To China Spending Decline

Shares of Applied Materials are down on Friday despite upbeat Q4 earnings. Analysts note solid beat, China slowdown, and strong growth in advanced foundry/logic and DRAM/HBM.

Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion

Halozyme offers to acquire Evotec for €11.00 per share, boosting Evotec's value to €2 billion. The merger aims to enhance Halozyme's revenue growth and portfolio.

S&P 500 Down Over 1%; US Retail Sales Top Expectations

Kulicke And Soffa Industries Likely To Win Order From Leading Semiconductor Company, Says Bullish Analyst

Shares of KLIC rose on Friday after the announcing an order from a major foundry. Analyst upgraded stock to Buy with $55 target price.

These Analysts Boost Their Forecasts On Intuitive Machines Following Q3 Earnings